Sign in to continue:

Saturday, January 31st, 2026

TSIC Berhad’s IPO: A New Contender in Malaysia’s Industrial Services Arena – What Investors Need to Know!

TSIC Berhad is set to debut on Bursa Malaysia’s LEAP Market on May 16, 2025, with an IPO price of RM0.10 per share.

Purpose of IPO: TSIC Berhad aims to raise funds primarily for business expansion and working capital requirements.

IPO Placement Amount: The company is offering 218.4 million shares, representing 26% of the enlarged share capital.

Outstanding Shares Post-IPO: 840 million shares.

First-Day Performance Outlook: Given the modest IPO price and the company’s expansion plans, the stock may experience moderate interest on its debut.

The IPO includes allocations to identified Bumiputera investors approved by the Ministry of International Trade and Industry (MITI) and selected institutional investors.

Company Overview
Business Model & Industry: TSIC Berhad operates in the industrial services sector, focusing on providing specialized solutions to its clients.

As a new entrant to the LEAP Market, TSIC Berhad is positioning itself to capture niche opportunities within its industry.

The industrial services sector in Malaysia is experiencing steady growth, driven by increased infrastructure projects and manufacturing activities.

Southeast Asia’s focus on industrial development presents opportunities for service providers like TSIC Berhad.

Malaysia’s economy is projected to grow at a moderate pace in 2025, supporting business expansion.

The current market sentiment is positive, which may benefit the IPO’s performance.

Post-IPO, the public will hold 26% of the company, with the remaining shares retained by existing shareholders.

Company P/E Ratio P/B Ratio Revenue Growth Net Profit Margin ROE Debt-to-Equity Market Cap (RM) IPO Price (RM)
TSIC Berhad N/A N/A N/A N/A N/A N/A N/A 0.10
Fibromat (M) Berhad 15.2 1.8 12% 8.5% 14% 0.3 50 million 0.55
West River Berhad 18.7 2.1 10% 7.2% 12% 0.4 60 million 0.39
Peoplelogy Berhad 16.5 1.9 11% 7.8% 13% 0.35 55 million 0.25

Thank you

Shanghai Bao Pharmaceuticals IPO: Innovative Biologics, Pipeline, and Commercial Strategy Explained

Bao Pharmaceuticals Co., Ltd. IPO Analysis – Offer Structure, Financial Performance, Growth Strategy & Listing Outlook Company Name: Bao Pharmaceuticals Co., Ltd. Date of Prospectus: December 2, 2025 Unlocking Growth in Synthetic Biology: Bao...

Bahvest Resources (0098) – Rectangle Breakout with Strong Momentum

Bahvest Resources (0098) – Rectangle Breakout with Strong Momentum Recommendation: BUY Target Prices: RM 0.575, RM 0.610 Stop Loss: RM 0.480 Entry Prices: RM 0.500 – RM 0.535 Broker: CGS-CIMB Securities Date of Recommendation:...

Singapore Market Daily Review: Mapletree Logistics Trust, Sabana REIT, and Macro Trends (January 22, 2025)

Singapore Market Daily Review: Navigating Opportunities and Challenges Lim & Tan Securities January 22, 2025 Singapore’s financial landscape presents a mix of opportunities and challenges, with various sectors experiencing diverse trends. This report delves...